Background illustration for clinical trials search

Paid Clinical Trials Worcester

Discover 3,086 paid clinical trials in Worcester, Massachusetts. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Modular Approach for Autism Programs in Schools

for
Autism Spectrum Disorder
Location: Randolph MA, Rochester NY, Tampa FL
Sponsor: May Institute

Sex: All

Age: 5 - 12

Code: NCT04533607

Recruiting

PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV)

for
Hematologic Malignancies,
Location: Boston MA, Hackensack NJ, Baltimore MD, Detroit MI,
Sponsor: Pulmotect, Inc.

Sex: All

Age: 18+

Code: NCT06665100

Phase 2, Recruiting

VE303 for Prevention of Recurrent Clostridioides Difficile Infection

for
Clostridium Difficile, Clostridium Difficile Infections,
Location: Boston MA, Bristol CT, Hamden CT, Manhasset NY,
Sponsor: Vedanta Biosciences, Inc.

Sex: All

Age: 12+

Code: NCT06237452

Phase 3, Recruiting

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

for
Solid Tumor, Advanced Solid Tumor, Solid Tumor, Adult,
Location: Boston MA, Hackensack NJ, Philadelphia PA, Fairfax VA,
Sponsor: NiKang Therapeutics, Inc.

Sex: All

Age: 19+

Code: NCT06586957

Phase 1, Recruiting

Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration

for
Solid Tumors
Location: Boston MA, New Haven CT, New York NY, Philadelphia PA,
Sponsor: ORIC Pharmaceuticals

Sex: All

Age: 18+

Code: NCT05315700

Phase 1, Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Treatment of Brain AVMs (TOBAS) Study

for
Unruptured Brain Arteriovenous Malformation,
Location: Boston MA, Montreal, Jacksonville FL, Albuquerque NM,
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)

Sex: All

Age: 5+

Code: NCT02098252

Recruiting

A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)

for
Locally Advanced Solid Tumor, Metastatic Solid Tumor
Location: Boston MA, New York NY, Philadelphia PA, Ottawa,
Sponsor: Nuvalent Inc.

Sex: All

Age: 12+

Code: NCT05384626

Phase 1, Phase 2, Recruiting

GpCRC Pediatric Gastroparesis Registry 2

for
Gastroparesis, Gastroparesis-like Syndrome
Location: Boston MA, Columbus OH, Milwaukee WI, Houston TX,
Sponsor: Johns Hopkins Bloomberg School of Public Health

Sex: All

Age: 8 - 25

Code: NCT05981300

Recruiting

Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)

for
Non-Hodgkin Lymphoma, B-cell Acute Lymphoblastic Leukemia,
Location: Providence RI, Boston MA, New York NY, Baltimore MD,
Sponsor: Imugene Limited

Sex: All

Age: 18+

Code: NCT03666000

Phase 1, Recruiting

The PREDICT Registry:

for
DCIS, Stage 0 Breast Cancer, Ductal Breast Carcinoma In Situ
Location: Boston MA, Mineola NY, Lake Success NY, New York NY,
Sponsor: PreludeDx

Sex: Female

Age: 30 - 70+

Code: NCT03448926

Recruiting

ATTUNE: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intrathecally-Administered ION440 in Participants With Methyl CpG Binding Protein 2 (MECP2) Duplication Syndrome (MDS)

for
Methyl CpG Binding Protein 2 (MECP2) Duplication Syndrome
Location: Boston MA, Philadelphia PA, Baltimore MD, Nashville TN,
Sponsor: Ionis Pharmaceuticals, Inc.

Sex: Male

Age: 2 - 65

Code: NCT06430385

Phase 1, Phase 2, Recruiting

A Study to Evaluate Tovorafenib in Pediatric and Young Adult Participants With Relapsed or Progressive Low-Grade Glioma and Advance Solid Tumors

for
Low-grade Glioma, Advanced Solid Tumor
Location: Boston MA, New York NY, Philadelphia PA, Montreal,
Sponsor: Day One Biopharmaceuticals, Inc.

Sex: All

Age: 0 - 25

Code: NCT04775485

Phase 2, Recruiting

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

for
Metastatic Breast Cancer, Metastatic Gastric Adenocarcinoma,
Location: Boston MA, New Haven CT, Shirley NY, New York NY,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT06324357

Phase 1, Phase 2, Recruiting

Phase 1 Study of Intratumoral Administration of VAX014 With Expansion in Combination With a Checkpoint Inhibitor in Subjects With Advanced Solid Tumors

for
Advanced Solid Tumor,
Location: Boston MA, Lebanon NH, Morristown NJ,
Sponsor: Vaxiion Therapeutics

Sex: All

Age: 18+

Code: NCT05901285

Phase 1, Recruiting

Resource Intervention to Support Equity (RISE) in High-Risk Neuroblastoma

for
Neuroblastoma, High-risk Neuroblastoma
Location: Boston MA, Hartford CT, New York NY, Philadelphia PA,
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 0 - 17

Code: NCT06831552

Recruiting

Genetics of Epilepsy and Related Disorders

for
Epilepsy, Epileptic Encephalopathy
Location: Boston MA
Sponsor: Boston Children's Hospital

Sex: All

Age: 0+

Code: NCT01858285

Recruiting

Cardiac Sarcoidosis Randomized Trial

for
Cardiac Sarcoidosis, Sarcoidosis
Location: Boston MA, New Haven CT, New York NY, Sherbrooke,
Sponsor: Ottawa Heart Institute Research Corporation

Sex: All

Age: 18+

Code: NCT03593759

Phase 3, Recruiting

Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function

for
Heart Failure and Impaired Kidney Function
Location: Providence RI, Boston MA, Clifton Park NY, The Bronx NY,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT06307652

Phase 3, Recruiting

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

for
Ovarian Carcinoma
Location: Boston MA, Providence RI, Springfield MA, Hartford CT,
Sponsor: NRG Oncology

Sex: Female

Age: 35 - 50

Code: NCT04251052

Recruiting

Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors

for
Locally Advanced Solid Tumor
Location: Boston MA, New York NY, Fairfax VA, Detroit MI,
Sponsor: Tango Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT05732831

Phase 1, Phase 2, Recruiting